Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Forecast to 2031 - Regional Analysis - by Delivery Mode (Cloud Based and On-Premises), Application (Oncology, Respiratory, and Others), and End User

Description

List of Tables

The Middle East & Africa electronic patient-reported outcomes (ePROS) market was valued at US$ 23.79 million in 2023 and is expected to reach US$ 60.23 million by 2031; it is estimated to register a CAGR of 12.3% from 2023 to 2031.

Integration of Artificial Intelligence and Machine Learning with ePROS Platforms Bolsters Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market

EPRO platforms integrate artificial intelligence (AI) and machine learning (ML) to improve data analysis and predictive analytics. Using these technologies, patterns in patient-reported data can be found, allowing for more individualized treatment plans and early detection of possible health problems. Deeper insights are also obtained by analyzing patient free-text responses using AI-driven natural language processing (NLP). For example, Medable, the digital health platform, and Clario integrate AI with their ePRO solutions to improve patient involvement, data accuracy, and real-time insights in clinical trials. These technological advancements are transforming ePRO systems, making them more efficient, accessible, and a major part of the digital health ecosystem. In August 2023, the next-generation, cutting-edge software platform from assisTek, a Pennsylvania-based Clinical Technology company, was intended to streamline their current eCOA (electronic Clinical Outcome Assessments) and ePRO (electronic Patient-Reported Outcomes) solutions. This state-of-the-art platform incorporates new features and upgrades, such as a proprietary custom operating system, AI-powered configurator, remote device provisioning for improved reusability, and single sign-on (SSO). Thus, the integration of artificial intelligence and machine learning with ePROS platforms, which offers new capabilities to enhance patient data collection, analysis, and integration, is expected to bring new trends in the electronic patient-reported outcomes (ePROS) market in the coming years.

Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Overview

The Government of Saudi Arabia has been actively working to strengthen its healthcare sector and promote clinical research within the country. The government has implemented several initiatives to attract clinical trials and increase the participation of Saudi Arabian sites in international studies. In addition, the increasing focus on digital health technologies is owing to the various advantages offered by the technology that improves the quality of care in healthcare. The country is experiencing significant growth opportunities in digital health owing to the surging investments and collaboration between tech firms and healthcare providers in the healthcare sector in Saudi Arabia. These partnerships are crucial for developing innovative digital health solutions designed to meet the specific needs of the Saudi Arabian market. The government's strategic initiative, particularly through initiatives such as Saudi Vision 2030, is fostering a supportive environment for digital health technologies. This initiative is facilitating the use of mobile health apps, telemedicine services, and advanced wearable devices across the country. Under Saudi Vision 2030, more than US$ 65 billion will be spent on the development of the healthcare system in Saudi Arabia. Therefore, increasing digitization in healthcare and surging clinical trials are anticipated to fuel the growth of the electronic related-patient outcomes (ePROS) market in the coming years.

Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Revenue and Forecast to 2031 (US$ Million)

Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Segmentation

The Middle East & Africa electronic patient-reported outcomes (ePROS) market is categorized into delivery mode, application, end user, and country.

By delivery mode, the Middle East & Africa electronic patient-reported outcomes (ePROS) market is bifurcated into cloud based and on-premises. The cloud based segment held a larger share of the Middle East & Africa electronic patient-reported outcomes (ePROS) market share in 2023.

In terms of application, the Middle East & Africa electronic patient-reported outcomes (ePROS) market is segmented into oncology, respiratory, and others. The oncology segment held the largest share of the Middle East & Africa electronic patient-reported outcomes (ePROS) market share in 2023.

By end user, the Middle East & Africa electronic patient-reported outcomes (ePROS) market is segmented into contract research organizations (CROs), pharmaceutical companies, and others. The pharmaceutical companies segment held the largest share of the Middle East & Africa electronic patient-reported outcomes (ePROS) market share in 2023.

Based on country, the Middle East & Africa electronic patient-reported outcomes (ePROS) market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia segment held the largest share of Middle East & Africa electronic patient-reported outcomes (ePROS) market in 2023.

Assistek, Buddy Healthcare Ltd Oy, Castor, Clinical Ink Inc, Crucial Data Solutions, Curebase, Medable Inc, Medidata Solutions, Medrio, OpenClinica LLC, PatientIQ, Signant Health, Veeva Systems Inc, and Y-Prime LLC are the among leading companies operating in the Middle East & Africa electronic patient-reported outcomes (ePROS) market.

Product Code: BMIRE00031354

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:

.2.2 Macro-economic factor analysis:

3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Benefits of ePROs
4.4 Use of ePRO in Clinical Trials
4.5 List of Hospitals Using ePRO country

5. Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market - Key Market Dynamics

5.1 Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Emerging Applications of Electronic Patient-Reported Outcomes (ePROS)
- 5.2.2 Increasing Focus on Patient-Centered Care
5.3 Market Restraints
- 5.3.1 Data Privacy and Security Issues
5.4 Market Opportunities
- 5.4.1 Rising Adoption of Telehealth and Remote Monitoring
5.5 Future Trends
- 5.5.1 Integration of Artificial Intelligence and Machine Learning with ePROS Platforms
5.6 Impact of Drivers and Restraints:

6. Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market - Analysis

6.1 Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Revenue (US$ Million), 2021-2031
6.2 Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Forecast Analysis

7. Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Analysis - by Delivery Mode

7.1 Cloud Based
- 7.1.1 Overview
- 7.1.2 Cloud Based: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 On-Premise
- 7.2.1 Overview
- 7.2.2 On-Premise: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Analysis - by Application

8.1 Oncology
- 8.1.1 Overview
- 8.1.2 Oncology: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Respiratory
- 8.2.1 Overview
- 8.2.2 Respiratory: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Analysis - by End User

9.1 CROs
- 9.1.1 Overview
- 9.1.2 CROs: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Pharmaceutical Companies
- 9.2.1 Overview
- 9.2.2 Pharmaceutical Companies: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market - Country Analysis

10.1 Middle East & Africa
- 10.1.1 Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 Saudi Arabia: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 Saudi Arabia: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Share - by Delivery Mode
    - 10.1.1.2.2 Saudi Arabia: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Share - by Application
    - 10.1.1.2.3 Saudi Arabia: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Share - by End User
  - 10.1.1.3 South Africa: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 South Africa: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Share - by Delivery Mode
    - 10.1.1.3.2 South Africa: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Share - by Application
    - 10.1.1.3.3 South Africa: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Share - by End User
  - 10.1.1.4 United Arab Emirates: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 United Arab Emirates: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Share - by Delivery Mode
    - 10.1.1.4.2 United Arab Emirates: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Share - by Application
    - 10.1.1.4.3 United Arab Emirates: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Share - by End User
  - 10.1.1.5 Rest of Middle East & Africa: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.5.1 Rest of Middle East & Africa: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Share - by Delivery Mode
    - 10.1.1.5.2 Rest of Middle East & Africa: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Share - by Application
    - 10.1.1.5.3 Rest of Middle East & Africa: Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Share - by End User

11. Industry Landscape

11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations

12. Company Profiles

12.1 OpenClinica LLC
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Buddy Healthcare Ltd Oy
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Castor
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Medable Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Assistek
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Signant Health
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Crucial Data Solutions
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Curebase
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Y-Prime LLC
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Clinical Ink Inc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Medidata Solutions
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 Veeva Systems Inc
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
12.13 Medrio
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments
12.14 PatientIQ
- 12.14.1 Key Facts
- 12.14.2 Business Description
- 12.14.3 Products and Services
- 12.14.4 Financial Overview
- 12.14.5 SWOT Analysis
- 12.14.6 Key Developments

13. Appendix

13.1 About Us
13.2 List of Abbreviations